M&T Bank Corp Spring Works Therapeutics, Inc. Transaction History
M&T Bank Corp
- $231 Billion
- Q4 2024
A detailed history of M&T Bank Corp transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, M&T Bank Corp holds 20,155 shares of SWTX stock, worth $1.18 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,155
Previous 17,381
15.96%
Holding current value
$1.18 Million
Previous $556,000
30.94%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding SWTX
# of Institutions
234Shares Held
69.6MCall Options Held
145KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA7.16MShares$419 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$329 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.52MShares$206 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.46MShares$203 Million5.51% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$200 Million5.82% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $3.66B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...